Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Leafs4Lifeon Apr 23, 2018 12:10pm
139 Views
Post# 27926640

RE:RE:RE:RE:RE:RE:RE:FYI

RE:RE:RE:RE:RE:RE:RE:FYIThey can and have produced lots of product: from news on March 8th, "The CSPA Group has been test marketing the core product in selected retail stores in California and the initial results have been very positive. The new product line Reveur (the French word for Dreamer) will focus on the higher upscale luxury market using only fresh frozen organically grown cannabis strains processed at minus 50 degrees preserving all the natural terpenes and flavonoids. The company has produced 15,000 grams of Reveur live resin products in February. The Reveur product launch will begin March 15, 2018, with deliveries to strategically targeted retailers throughout California."

When I spoke with Phil he told me that they had continued to produce Reveur throughout March, and we've seen enough Cannastrip samples on Instagram to infer that they've been producing those too.

As to why they have not shipped products to dispensaries yet? Your guess is as good as mine. There was a rumour that the shipping company had a paperwork snafu, but that shouldn't take a month to fix. 

Anyway, the problem isn't capacity or production. It's shipping and sales and (in my opinion) getting distracted by things like Coachella. 


badog222 wrote: I guess if you can't produce much product....then festivals would be the the way to go.    Dispensaries would probably expect you to supply a lot of product.   

It's not that I have a problem with festivals putting your name out there...but I do not understand making it your primary route for sales.   It won't sell enough to pay the bills and finish building the facilities.    Well, probably won't even pay the bills.    If this keeps up I would guess another PP/dilution could be in order.


Bullboard Posts